| 摘要 |
FIELD: medicine.SUBSTANCE: present invention relates to methods for identifying individuals with intermediate age-related macular degeneration (AMD) who possess a greater risk of progression to advanced AMD, using a polygenic score calculated based on results of genome-wide gene association studies, using thousands of single-nucleotide polymorphisms (SNP).EFFECT: method can be used in medicine.25 cl, 3 dwg, 2 tbl, 1 ex |
